Named on 5 rounds in the feed, most often in Biotech.
Rounds from 2025-05-19 to 2026-10-29
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Opentrons Labworks A laboratory robotics and automation company | Series E Verified against 1 of 160 sources | $40M | 2026-10-29 | [ PART ] |
CellCentric A drug-discovery platform | Series D Verified against 4 of 7 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $220M | 2026-05-06 | [ PART ] |
Alveus Therapeutics Alveustx specializes in developing next-generation treatments for obesity and metabolic diseases. | Series A ext. Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $197M financing total | 2026-02-24 | [ PART ] |
Alveus Therapeutics Alveustx specializes in developing next-generation treatments for obesity and metabolic diseases. | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $160M | 2026-01-08 | [ PART ] |
CellCentric A drug-discovery platform | Series C Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-05-19 | [ PART ] |